Related Experiment Video
Updated: Jul 27, 2026

09:06
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
MADGAN: unsupervised medical anomaly detection GAN using multiple adjacent brain MRI slice reconstruction
Changhee Han1, Leonardo Rundo2,3, Kohei Murao4
1LPIXEL Inc., Tokyo, Japan. han@lpixel.net.
BMC Bioinformatics
|April 27, 2021
Summary
This study introduces MADGAN, an unsupervised method for detecting brain anomalies like Alzheimer's disease and brain metastases using multi-sequence MRI scans. It accurately identifies early-stage Alzheimer's and brain tumors, outperforming previous methods.
Area of Science:
- Medical Imaging Analysis
- Artificial Intelligence in Healthcare
- Neuroscience Research
Background:
- Unsupervised learning in medical imaging typically reconstructs single slices, limiting detection of diseases with subtle anatomical anomalies like Alzheimer's disease (AD).
- Existing methods struggle to assess disease stages, multiple disease types, or multi-sequence MRI scans simultaneously.
- There is a need for unsupervised anomaly detection methods that consider slice continuity and multi-modal data.
Purpose of the Study:
- To develop a novel unsupervised method for detecting various brain anomalies, including Alzheimer's disease and brain metastases, using multi-sequence MRI.
- To improve the detection of subtle anatomical anomalies and hyper-intense lesions by considering the continuity between adjacent MRI slices.
- To evaluate the method's performance across different disease stages and types, and on different MRI sequences.
Main Methods:
- Proposed unsupervised Medical Anomaly Detection Generative Adversarial Network (MADGAN), a two-step approach utilizing GAN-based reconstruction of adjacent brain MRI slices.
- Employed Wasserstein loss with Gradient Penalty and a secondary loss for training on healthy brain MRI slices to reconstruct subsequent slices.
- Utilized self-attention mechanism within MADGAN for enhanced anomaly detection on T1-weighted and contrast-enhanced T1 MRI scans.
Main Results:
- MADGAN successfully detected early-stage Alzheimer's disease (Mild Cognitive Impairment) with an AUC of 0.727 and late-stage AD with an AUC of 0.894 on T1-weighted MRI scans.
- The method achieved an AUC of 0.921 in detecting brain metastases on contrast-enhanced T1 MRI scans.
- Demonstrated reliable prediction of healthy brain slices and accurate discrimination of unseen abnormal scans, validating the reconstruction and diagnosis steps.
Conclusions:
- MADGAN, as the first unsupervised method for multi-sequence MRI analysis, reliably predicts healthy slices and detects subtle anatomical anomalies and lesions.
- The approach effectively diagnoses conditions like Alzheimer's disease and brain metastases, showcasing its potential for various disease detection.
- This method mimics physician diagnostic strategies by learning from extensive healthy data, offering a new paradigm for unsupervised anomaly detection in medical imaging.

